Skip to main content
. 2014 Nov 3;6(6):1649–1656. doi: 10.4161/19420862.2014.976431

Table 3.

Summary of ch-mAb7F9 pharmacokinetic parameters by treatment

  AUC(0-inf) (μg*h/mL) AUC(0-last) (μg*h/mL) Cmax (μg/mL) tmaxa (h) t1/2 (h) CL (L/h) Vd (L)
0.2 mg/kg              
 n 6 6 6 6 6 6 6
 Mean 1400 1070 5.21 3.18 (2.03, 4.00) 341 0.0104 5.01
 SD 200 214 1.82 74.1 0.00173 0.652
0.6 mg/kg              
 n 6 6 6 6 6 6 6
 Mean 4620 4160 15.5 2.25 (2.25, 6.00) 383 0.0101 5.38
 SD 714 690 2.33 128 0.00204 1.73
2 mg/kg              
 n 5 5 6 6 5 5 5
 Mean 16800 16300 50.6 3.52 (2.25, 6.00) 432 0.00794 5.03
 SD 1520 1500 3.43 57.4 0.00134 1.43
6 mg/kg              
 n 6 6 6 6 6 6 6
 Mean 53500 53000 178 3.50 (2.00, 6.00) 418 0.00855 5.14
 SD 4640 4640 16.5 51.5 0.00109 0.743
20 mg/kg              
 n 6 6 7 7 6 6 6
 Mean 166000 165000 517 2.28 (2.00, 4.02) 460 0.00896 5.88
 SD 17700 17500 89.3 42.0 0.00273 1.51

Note(s): n = number of subjects; SD = standard deviation. aOnly median (minimum, maximum) are presented for tmax.